1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Ophthalmopathy: new trials by email Literature Review of Ophthalmopathy trials Research Report on Ophthalmopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO) Ranibizumab, triamcinolone acetate - Ophthalmopathy | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2019-05-16 | 2020-07-07 |
Eye Diseases (1)
Ranibizumab (1) · Triamcinolone (1)
Egypt (1)